Equity Real Estate Investment Trusts (REITs)

Healthpeak Properties

New York Life Q4 Increases Stake in Healthpeak Properties by 65.8%, Holding Reaches 156K Shares

Healthpeak Properties released FY2026 Q1 earnings on May 5 After-Market EST, actual revenue USD 752.95 M (forecast USD 693.13 M), actual EPS USD 0.2783 (forecast USD 0.0503)

Healthpeak Properties Announces Higher-than-Expected Q1 Net Income

Healthpeak Properties to Release FY2026 Q1 Earnings on May 5 After-Market EST, Forecast Revenue USD 693.13M, EPS USD 0.0503

Robeco Reduces Stake in Healthpeak Properties

HF Advisory Group LLC Buys New Position in Healthpeak Properties

Healthpeak Properties Releases Annual Report and Plans Janus Living REIT IPO

Healthpeak Properties Inc. Unveils Healthcare Real Estate Strategy and Plans Janus Living IPO

Healthpeak Properties released FY2025 earnings on February 2 After-Market EST, actual revenue USD 2.823 B (forecast USD 2.744 B), actual EPS USD 0.1013 (forecast USD 0.0043)

Healthpeak Properties released FY2025 Q4 earnings on February 2 After-Market EST, actual revenue USD 719.4 M (forecast USD 686.44 M), actual EPS USD 0.1602 (forecast USD 0.0714)

Healthpeak Properties Q4 net income beats expectations

Healthpeak Properties to release FY2025 Q4 earnings on February 2, 2026, after-market EST; forecast revenue USD 690.15 M, EPS USD 0.0714

Healthpeak Properties Inc. Completes $925 Million Asset Transaction, Including $600 Million Acquisition in South San Francisco

Healthpeak Properties Inc Target Price Downgraded by Analysts

FactSet lowers EPS forecast for Healthpeak Properties Inc to 0.01 USD for 2025

Healthpeak Properties Releases New Investor Presentation

Ethic Inc. Reduces Holdings in Healthpeak Properties

D.A. Davidson & CO. increased stake in Healthpeak Properties

Healthpeak Properties Reports Business Turnaround and Announces Merger with Physicians Realty Trust

Yulico Recommends Real Estate Stocks, Morgan Stanley Maintains Buy Rating on Healthpeak Properties

OPTIMI HEALTH CORP

HCW Biologics

GCL Global

Silexion Therapeutics

Micware

Vida Global

BiomX

MicroAlgo

MetaVia

Quantum Cyber NV

Ordinary dividend (cash)

Ex Date: 2026.06.15 (EST), Cash dividend 0.1016 USD

WTRE

GQRE

XLRE

REET

SCHH

New York Life Investment Management LLC increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 65.8% in Q4, owning 156,086 shares valued at $2.51 million. Other institutional investors also boosted their holdings. Healthpeak Properties has a consensus rating of 'Hold' with an average price target of $18.92. The stock opened at $19.53, with a 12-month range of $15.70 to $19.91. The company reported $0.45 EPS for the last quarter, exceeding estimates.

Market Beat

WisdomTree New Economy Real Estate Fund

iShares US Real Estate ETF

SPDR Dow Jones REIT ETF

FlexShares Glbl Quality Real Estate ETF

iShares Residential and Multisector Real Estate ETF

SPDR Dow Jones Global Real Estate ETF

Real Est Select Spdr

iShares Global REIT

Schw Us Reit

Vanguard Real Estate ETF

Digitalocean

Bank of Nova Scottia

Morgan Stanley

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

New York Life Investment Management LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC

Healthpeak Properties Inc. (DOC) shares fell 1.02% to $19.36 amid a poor trading session, while the S&P 500 and Dow Jones also declined. Despite this, Healthpeak outperformed competitors like Alexandria Real Estate Equities, Ventas, and BXP, which saw larger losses. The stock remains 2.76% below its 52-week high of $19.91.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Alexandria Real Estate Eq

Ventas

Factset Research

Healthpeak Properties Inc. Stock Outperforms Competitors Despite Losses On The Day

Healthpeak Properties (NYSE:DOC) reached a new 52-week high of $19.91 after UBS Group raised its price target from $17.00 to $19.00, maintaining a neutral rating. Other brokerages also adjusted their ratings, with Robert W. Baird increasing its target to $21.00 and Citigroup to $20.00. The stock's average rating is 'Hold' with a consensus target price of $18.75. Institutional investors own 93.57% of the stock, and Healthpeak reported a quarterly EPS of $0.45, exceeding estimates.

UBS Group AG

Citigroup

State Street

JPMorgan Chase

Invesco

CITIGROUP INC 6.250 NON CUM SER II PFD WI

State Street® US Equity Premium Inc ETF

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Healthpeak Properties (NYSE:DOC) Hits New 1-Year High After Analyst Upgrade

Ingersoll Rand Inc. (IR) shares fell 2.49% to $71.39 on Wednesday, marking the fifth consecutive day of losses. The stock is currently 29.29% below its 52-week high of $100.96. Ingersoll Rand underperformed compared to competitors like Deere & Co., Dover Corp., and IDEX Corp., which also saw declines. The trading volume was 5.4 million, surpassing the 50-day average of 3.5 million.

Ingersoll Rand

Deere

Dover

Idex

Ingersoll Rand Inc. Stock Underperforms Wednesday When Compared To Competitors

Healthpeak Properties (NYSE:DOC) reported Q1 2026 adjusted funds from operations of $0.45 per share, raising its full-year guidance after significant capital moves, including a senior housing IPO and a $100 million stock repurchase. CEO Scott Brinker highlighted strong performance in life sciences and outpatient medical sectors, with net debt to EBITDA at 5.4 times. The IPO of Janus Living is expected to be neutral in 2026 but accretive thereafter. The outpatient medical segment showed robust leasing activity, achieving 5.4% cash re-leasing spreads and 91% occupancy. Life science occupancy improved to 77.7%.

Janus Living

iShares US Healthcare Providers

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

SPDR S&P Health

iShares Biotechnology ETF

Health Care Select Sector SPDR

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

VG Health

Direxion S&P Biotech Bear 3X

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

Blackstone

HCA Healthcare

Healthpeak Properties Q1 Earnings Call Highlights

Real estate stocks showed slight gains despite underperforming the broader market, driven by individual earnings announcements. The S&P 500 Real Estate Index rose 0.06%, while Healthpeak Properties led large-cap gainers with a 19.61% increase. Americold Realty Trust topped mid-cap gainers with a 20.85% jump. Notable losers included CoStar Group, down 5.62%, and Realty Income, which saw a 2.96% decline despite strong earnings. Overall, the sector remains positive year-to-date, with mixed performances across various indices and companies.

Healthpeak Properties(DOC.US)

New York Life Investment Management LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC

Healthpeak Properties Inc. Stock Outperforms Competitors Despite Losses On The Day

Healthpeak Properties (NYSE:DOC) Hits New 1-Year High After Analyst Upgrade

Ingersoll Rand Inc. Stock Underperforms Wednesday When Compared To Competitors

Healthpeak Properties Q1 Earnings Call Highlights

Real estate stocks eke out gains on earnings releases

Are Wall Street Analysts Bullish on Healthpeak Properties Stock?

Trending